Skip To Main Content

Actualización normativa

En un entorno en constante cambio como el sistema de salud, es fundamental mantenerse al día con las nuevas normativas que afectan tanto a profesionales como a pacientes. En este espacio encontrará las leyes, decretos, resoluciones y acuerdos relacionados con el sistema de salud dinámico y en evolución.

También encontrará resúmenes, análisis y todo lo relacionado con la más reciente normatividad, para comprender el posible impacto de los cambios hacia los diferentes actores del sistema.

Ordenar por
Inside MS: Explore how BTK drives immune cell activation and CNS damage

Inside MS: Explore how BTK drives immune cell activation and CNS damage

Discover the science behind Tolebrutinib: a BTK inhibitor designed to slow MS disability progression by modulating adaptive and innate immunity

Discover the science behind Tolebrutinib: a BTK inhibitor designed to slow MS disability progression by modulating adaptive and innate immunity

Discover the science behind Tolebrutinib: a BTK inhibitor designed to slow MS disability progression by modulating adaptive and innate immunity

Discover the science behind Tolebrutinib: a BTK inhibitor designed to slow MS disability progression by modulating adaptive and innate immunity

Inside MS: Explore how BTK drives immune cell activation and CNS damage

Inside MS: Explore how BTK drives immune cell activation and CNS damage

T1D: Debunking the Age Myth

T1D: Debunking the Age Myth

An infographic describing the prevalence of and challenges faced in diagnosing adult-onset T1D 

IMD: Why Every Hour Matters in Meningococcal Disease Management

IMD: Why Every Hour Matters in Meningococcal Disease Management

Learn about the rapid progression of Invasive Meningococcal Disease (IMD), its clinical manifestations, and why early diagnosis is crucial for patient survival.

IMD Complications & Family Burden: Understanding the Multi-dimensional Impact

IMD Complications & Family Burden: Understanding the Multi-dimensional Impact

Explore the comprehensive impact of Invasive Meningococcal Disease (IMD), including family burden, survivor complications, and quality of life effects. Learn about neurological and non-neurological complications affecting IMD survivors.

Cumulative Life Course Impairment (CLCI) in Atopic Dermatitis

Cumulative Life Course Impairment (CLCI) in Atopic Dermatitis

Cumulative Life Course Impairment (CLCI) in Atopic Dermatitis

Cumulative Life Course Impairment (CLCI) in Atopic Dermatitis

 Nuevas Fronteras en Diabetes Tipo 1

Nuevas Fronteras en Diabetes Tipo 1

Polyp Gossip – Episode 5

Polyp Gossip Episode 5: Personalized Care for CRSwNP: Finding What Works Best for You

In this episode of Polyp Gossip, we explore the power of personalized care in CRSwNP. From symptoms to patient profiles, our experts discuss how tailored treatment strategies can lead to better outcomes and improved quality of life. Tune in to discover what "finding what works best for you" really means in today's evolving care landscape.

LixiLan-G Çalışması: GLP-1 RA Tedavisiyle Yetersiz Kontrol Sağlanan T2DM Hastalarında iGlarLixi’ye Geçişin Etkililiği ve Güvenliliği

LixiLan-G Çalışması: GLP-1 RA Tedavisiyle Yetersiz Kontrol Sağlanan T2DM Hastalarında iGlarLixi’ye Geçişin Etkililiği ve Güvenliliği

Material diseñado por o para Sanofi Aventis de Colombia S.A., con fines educativos y dirigido a profesionales de la salud y personal administrativo del sector salud. Es estrictamente prohibido compartir este material con terceros.

Mayor información a disposición en el Departamento Médico:

En Colombia:

Sanofi-Aventis de Colombia S.A. Transversal 23 N° 97-73 - Edificio City Business. Piso 8. Bogotá D.C. Teléfono: 621 4400 - Fax: 744 4237

infomedica.colombia@sanofi.com

En Bolivia, Centro América y Caribe:

Sanofi-Aventis de Panamá S.A. Torre Evolution, piso 26, Calle 50 y Av. Aquilino de la Guardia Obarrio- Cuidad de Panamá, República de Panamá Telf.: (507) 382-9500. infomed.pac@sanofi.com

Sitio web: http://www.sanofi.com.pa/l/pa/sp/index.jsp

 

MAT-CO-2400825 V1.0 03/2024